Literature DB >> 22457360

Endothelin induces rapid, dynamin-mediated budding of endothelial caveolae rich in ET-B.

Phil Oh1, Thierry Horner, Halina Witkiewicz, Jan E Schnitzer.   

Abstract

Clathrin-independent trafficking pathways for internalizing G protein-coupled receptors (GPCRs) remain undefined. Clathrin-mediated endocytosis of receptors including ligand-engaged GPCRs can be very rapid and comprehensive (<10 min). Caveolae-mediated endocytosis of ligands and antibodies has been reported to be much slower in cell culture (≫10 min). Little is known about the role of physiological ligands and specific GPCRs in regulating caveolae trafficking. Here, we find that one receptor for endothelin, ET-B but not ET-A, resides on endothelial cell surfaces in both tissue and cell culture primarily concentrated within caveolae. Reconstituted cell-free budding assays show that endothelins (ETs) induce the fission of caveolae from endothelial plasma membranes purified from rat lungs. Electron microcopy of lung tissue sections and tissue subcellular fractionation both show that endothelin administered intravascularly in rats also induces a significant loss of caveolae at the luminal surface of lung vascular endothelium. Endothelial cells in culture show that ET stimulates very rapid internalization of caveolae and cargo including caveolin, caveolae-targeting antibody, and itself. The ET-B inhibitor BQ788, but not the ET-A inhibitor BQ123, blocks the ET-induced budding of caveolae. Both the pharmacological inhibitor Dynasore and the genetic dominant negative K44A mutant of dynamin prevent this induced budding and internalization of caveolae. Also shRNA lentivirus knockdown of caveolin-1 expression prevents rapid internalization of ET and ET-B. It appears that endothelin can engage ET-B already highly concentrated in caveolae of endothelial cells to induce very rapid caveolae fission and endocytosis. This transport requires active dynamin function. Caveolae trafficking may occur more rapidly than previously documented when it is stimulated by a specific ligand to signaling receptors already located in caveolae before ligand engagement.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22457360      PMCID: PMC3366858          DOI: 10.1074/jbc.M111.338897

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity.

Authors:  A Claing; S J Perry; M Achiriloaie; J K Walker; J P Albanesi; R J Lefkowitz; R T Premont
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Regulation and intracellular trafficking pathways of the endothelin receptors.

Authors:  T Bremnes; J D Paasche; A Mehlum; C Sandberg; B Bremnes; H Attramadal
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

Review 3.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.

Authors:  S S Ferguson
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

4.  Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling.

Authors:  C Dessy; R A Kelly; J L Balligand; O Feron
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

5.  Nucleotide-dependent conformational changes in dynamin: evidence for a mechanochemical molecular spring.

Authors:  M H Stowell; B Marks; P Wigge; H T McMahon
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

Review 6.  Biochemical and proteomic approaches for the study of membrane microdomains.

Authors:  Yu Zi Zheng; Leonard J Foster
Journal:  J Proteomics       Date:  2008-09-27       Impact factor: 4.044

7.  Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupied endothelin B receptor.

Authors:  A Oksche; G Boese; A Horstmeyer; J Furkert; M Beyermann; M Bienert; W Rosenthal
Journal:  Mol Pharmacol       Date:  2000-06       Impact factor: 4.436

8.  Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default.

Authors:  P Oh; J E Schnitzer
Journal:  Mol Biol Cell       Date:  2001-03       Impact factor: 4.138

9.  Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction.

Authors:  J Igarashi; T Michel
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

10.  Cholesterol oxidation switches the internalization pathway of endothelin receptor type A from caveolae to clathrin-coated pits in Chinese hamster ovary cells.

Authors:  Y Okamoto; H Ninomiya; S Miwa; T Masaki
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

View more
  11 in total

1.  Immunomodulatory glycan lacto-N-fucopentaose III requires clathrin-mediated endocytosis to induce alternative activation of antigen-presenting cells.

Authors:  Leena Srivastava; Smanla Tundup; Beak-San Choi; Thomas Norberg; Donald Harn
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

2.  Clathrin-independent pathways of endocytosis.

Authors:  Satyajit Mayor; Robert G Parton; Julie G Donaldson
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-06-02       Impact factor: 10.005

3.  Flumazenil decreases surface expression of α4β2δ GABAA receptors by increasing the rate of receptor internalization.

Authors:  Aarti Kuver; Sheryl S Smith
Journal:  Brain Res Bull       Date:  2015-11-22       Impact factor: 4.077

4.  Protein Kinase D and Gβγ Subunits Mediate Agonist-evoked Translocation of Protease-activated Receptor-2 from the Golgi Apparatus to the Plasma Membrane.

Authors:  Dane D Jensen; Peishen Zhao; Nestor N Jimenez-Vargas; TinaMarie Lieu; Marina Gerges; Holly R Yeatman; Meritxell Canals; Stephen J Vanner; Daniel P Poole; Nigel W Bunnett
Journal:  J Biol Chem       Date:  2016-03-30       Impact factor: 5.157

5.  Human Cytomegalovirus Up-Regulates Endothelin Receptor Type B: Implication for Vasculopathies?

Authors:  Koon-Chu Yaiw; Abdul-Aleem Mohammad; Helena Costa; Chato Taher; Sigrun Badrnya; Alice Assinger; Vanessa Wilhelmi; Sharan Ananthaseshan; Atosa Estekizadeh; Belghis Davoudi; Olga Ovchinnikova; Eugene Shlyakhto; Arnar Rafnsson; Zahidul Khan; Lynn Butler; Afsar Rahbar; John Pernow; Cecilia Söderberg-Nauclér
Journal:  Open Forum Infect Dis       Date:  2015-12-24       Impact factor: 3.835

6.  Potential of caveolae in the therapy of cardiovascular and neurological diseases.

Authors:  Gemma Navarro; Dasiel O Borroto-Escuela; Kjell Fuxe; Rafael Franco
Journal:  Front Physiol       Date:  2014-09-30       Impact factor: 4.566

7.  Microparticle-Induced Activation of the Vascular Endothelium Requires Caveolin-1/Caveolae.

Authors:  Allison M Andrews; Victor Rizzo
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

8.  A novel role for myeloid endothelin-B receptors in hypertension.

Authors:  Alicja Czopek; Rebecca Moorhouse; Léa Guyonnet; Tariq Farrah; Olivia Lenoir; Elizabeth Owen; Job van Bragt; Hannah M Costello; Filippo Menolascina; Véronique Baudrie; David J Webb; David C Kluth; Matthew A Bailey; Pierre-Louis Tharaux; Neeraj Dhaun
Journal:  Eur Heart J       Date:  2019-03-01       Impact factor: 29.983

9.  PR3 and elastase alter PAR1 signaling and trigger vWF release via a calcium-independent mechanism from glomerular endothelial cells.

Authors:  Samantha P Tull; Anne Bevins; Sahithi Jyothsna Kuravi; Simon C Satchell; Bahjat Al-Ani; Stephen P Young; Lorraine Harper; Julie M Williams; George Ed Rainger; Caroline O S Savage
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

10.  Reconstituting ring-rafts in bud-mimicking topography of model membranes.

Authors:  Yong-Sang Ryu; In-Ho Lee; Jeng-Hun Suh; Seung Chul Park; Soojung Oh; Luke R Jordan; Nathan J Wittenberg; Sang-Hyun Oh; Noo Li Jeon; Byoungho Lee; Atul N Parikh; Sin-Doo Lee
Journal:  Nat Commun       Date:  2014-07-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.